ACHV Soared As Much As 145. What Awaits SRPT HTBX KPTI This Week

ACHV Soared As Much As 145%. What Awaits SRPT, HTBX, KPTI This Week?

21:36 EST 23 Feb 2019 | RTTNews

Clinical trials are major catalysts for biotech/pharma companies as positive study data can boost their stock price while unfavorable results can send the stocks plummeting.

Original Article: ACHV Soared As Much As 145%. What Awaits SRPT, HTBX, KPTI This Week?

More From BioPortfolio on "ACHV Soared As Much As 145%. What Awaits SRPT, HTBX, KPTI This Week?"